Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab

Journal of Thoracic Oncology

English

MTE07.01 From Radiation Oncology Perspective

Journal of Thoracic Oncology

English

P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P1.13-12 EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P1.15-18 the Impact of Patient Age on Clinical Outcomes in NSCLC: A National Study

Journal of Thoracic Oncology

English

MA15.03 PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial

Journal of Thoracic Oncology

English

P2.16-42 Standard Mediastinoscopy Versus Video-Assisted Mediastinoscopic Lymphadectomy in Clinical N1 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature May Identify Non-Responders to Anti PD-1 Treatment in NSCLC

Journal of Thoracic Oncology

English

P2.15-27 Lung Volume Change After Lobectomy Estimated by Three-Dimensional Image Analysis System

Journal of Thoracic Oncology

English

OA02.07 Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

Tracheoesophageal Fistula in a Patient With Advanced NSCLC Who Received Chemoradiotherapy and Ramucirumab

MTE07.01 From Radiation Oncology Perspective

P3.cr-09 MET-UBE2H Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma" With "MET Fusion as a Novel Mechanism of Acquired EGFR Resistance in Lung Adenocarcinoma

P1.13-12 EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma

P1.15-18 the Impact of Patient Age on Clinical Outcomes in NSCLC: A National Study

MA15.03 PD-L1 Expression in Untreated EGFRm Advanced NSCLC and Response to Osimertinib and SoC EGFR-TKIs in the FLAURA Trial

P2.16-42 Standard Mediastinoscopy Versus Video-Assisted Mediastinoscopic Lymphadectomy in Clinical N1 Non-Small Cell Lung Cancer

P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature May Identify Non-Responders to Anti PD-1 Treatment in NSCLC

P2.15-27 Lung Volume Change After Lobectomy Estimated by Three-Dimensional Image Analysis System

OA02.07 Updated Results of Phase 1 Study of DS-8201a in HER2-Expressing or –Mutated Advanced Non-Small-Cell Lung Cancer